{
    "pubmed_id": 35143473,
    "study_identifier": "PMID35143473_study-01",
    "study_name": "SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort",
    "publication_title": "SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort",
    "study_objective": "To identify the potential for SARS-CoV-2 reinfection",
    "study_description": "Identifying the potential for SARS-CoV-2 reinfection is crucial for understanding possible long-term epidemic dynamics. We analysed longitudinal PCR and serological testing data from a prospective cohort of 4,411 United States employees in 4 states between April 2020 and February 2021. We conducted a multivariable logistic regression investigating the association between baseline serological status and subsequent PCR test result in order to calculate an odds ratio for reinfection. We estimated an odds ratio for reinfection ranging from 0.14 (95% CI: 0.019 to 0.63) to 0.28 (95% CI: 0.05 to 1.1), implying that the presence of SARS-CoV-2 antibodies at baseline is associated with around 72% to 86% reduced odds of a subsequent PCR positive test based on our point estimates. This suggests that primary infection with SARS-CoV-2 provides protection against reinfection in the majority of individuals, at least over a 6-month time period. We also highlight 2 major sources of bias and uncertainty to be considered when estimating the relative risk of reinfection, confounders and the choice of baseline time point, and show how to account for both in reinfection analysis.",
    "primary_institution_name": "London School of Hygiene& Tropical Medicine",
    "study_personnel": [
        {
            "personnel_id": "PMID35143473_personnel-01",
            "honorific": "",
            "last_name": "Galit",
            "first_name": "Alter",
            "suffixes": "",
            "organization": "Harvard Univeristy",
            "orchid_id": "",
            "email": "galter@mgh.harvard.edu",
            "seronet_title_in_study": "Co-Principal Investigator",
            "role_in_study": "Investigator",
            "site_name": "Harvard Univeristy"
        }
    ],
    "study_file": [
        {
            "study_file_name": "pbio.3001531.s001.docx",
            "study_file_description": "Study Data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "pbio.3001531.s002.docx",
            "study_file_description": "Study Data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35143473_v1.2.3.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [
        {
            "link_name": "Github",
            "value": "https://github.com/EmilieFinch/covid-reinfection."
        }
    ],
    "research_focus": "Immune Response",
    "study_type": "Epidemiological Research",
    "keyword": [
        "Adolescent",
        "Adult",
        "Aged",
        "Antibodies Viral blood",
        "COVID-19 epidemiology",
        "COVID-19 immunology",
        "COVID-19 prevention & control",
        "COVID-19 Nucleic Acid Testing",
        "bCOVID-19 Serological Testing",
        "Humans",
        "Logistic Models",
        "Middle Aged",
        "Polymerase Chain Reaction",
        "Prospective Studies",
        "Reinfection immunology",
        "Reinfection prevention control",
        "SARS-CoV-2 immunology",
        "Seroepidemiologic Studies",
        "Time Factors",
        "United States epidemiology",
        "Workplace statistics numerical data",
        "Young Adult"
    ],
    "clinical_study_design": "Cross-sectional Study",
    "in_silico_model_type": "Epidemiological Model",
    "protocol": {
        "protocol_id": "PMID35143473_protocol-01",
        "protocol_file_name": "PMID35143473_protocol-01.txt",
        "protocol_name": "PMID35143473_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19"
    ],
    "sars_cov_2_vaccine_type": [
        "N/A"
    ],
    "clinical_outcome_measure": "SARS-CoV-2 reinfection",
    "enrollment_start_date": "2020-04-01",
    "enrollment_end_date": "2021-01-03",
    "number_of_study_subjects": 4411,
    "age_unit": "Years",
    "minimum_age": 18,
    "maximum_age": 71,
    "study_human_cohort": [
        {
            "arm_id": "PMID35143473_human_subject-01",
            "arm_name": "SpaceX emloyees",
            "study_population_description": "4,411 SpaceX employees with prior Covid-19 infection enrolled",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Hispanic or Latino"
            ],
            "race": [
                "White",
                "Black or African American",
                "Other"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "US: California",
                "US: Florida",
                "US: Texas",
                "US: Washington"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected",
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [
                "n/a"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID35143473_visit-01",
            "visit_name": "Model",
            "visit_order_number": 1,
            "visit_min_start_day": 1,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID35143473_human_subject-01"
            ],
            "associated_first_planned_visit_id": [
                "PMID35143473_visit-01"
            ],
            "assay_type": "PCR",
            "experiment_name": "PCR",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Other"
            ],
            "biospecimen_collection_point": [
                "n/a"
            ],
            "sars_cov_2_antigen": [],
            "assay_use": "",
            "manufacture": "",
            "catalog_number": "",
            "virus_target": [],
            "antibody_isotype": [],
            "reporting_units": "",
            "assay_reporting_format": ""
        }
    ],
    "geriatric_subjects": "Yes",
    "pediatric_subjects": "No",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "Yes",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID35143473_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35143473_inexcl-02",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "exclusion"
        },
        {
            "inclusion_exculusion_id": "PMID35143473_inexcl-03",
            "inclusion_criterion": "SARS-CoV-2 Antibodies Measured",
            "inclusion_criterion_category": "inclusion"
        }
    ],
    "suggestions": [
        "0.019",
        "0.05",
        "0.14",
        "0.28",
        "0.63",
        "1.1",
        "2020",
        "2021",
        "4,411",
        "6-month",
        "account",
        "adolescent",
        "adult",
        "aged",
        "also",
        "analysed",
        "analysis",
        "antibodies",
        "antibodies viral blood",
        "april",
        "around",
        "associated",
        "association",
        "based",
        "baseline",
        "bcovid-19 serological testing",
        "bias",
        "calculate",
        "choice",
        "cohort",
        "conducted",
        "confounders",
        "considered",
        "covid-19",
        "covid-19 epidemiology",
        "covid-19 immunology",
        "covid-19 nucleic acid testing",
        "covid-19 prevention & control",
        "cross-sectional",
        "crucial",
        "data",
        "dynamics",
        "employees",
        "epidemic",
        "epidemiological",
        "estimated",
        "estimates",
        "estimating",
        "february",
        "geriatric",
        "highlight",
        "humans",
        "hygiene",
        "identify",
        "identifying",
        "immune",
        "implying",
        "individuals",
        "infection",
        "investigating",
        "least",
        "logistic",
        "logistic models",
        "london",
        "long-term",
        "longitudinal",
        "major",
        "majority",
        "measured",
        "medicine",
        "middle aged",
        "months",
        "multicentre",
        "multivariable",
        "n/a",
        "odds",
        "order",
        "pcr",
        "pediatric",
        "period",
        "point",
        "polymerase chain reaction",
        "positive",
        "possible",
        "potential",
        "presence",
        "primary",
        "prospective",
        "prospective studies",
        "protect",
        "protection",
        "provides",
        "ranging",
        "ratio",
        "reduced",
        "regression",
        "reinfection",
        "reinfection immunology",
        "reinfection prevention control",
        "relative",
        "research",
        "response",
        "result",
        "risk",
        "sars-cov-2",
        "sars-cov-2 immunology",
        "school",
        "seroepidemiologic studies",
        "seroepidemiological",
        "serological",
        "show",
        "sources",
        "states",
        "status",
        "study",
        "subjects",
        "subsequent",
        "suggests",
        "test",
        "testing",
        "time",
        "time factors",
        "tropical",
        "uncertainty",
        "understanding",
        "united",
        "united states epidemiology",
        "workplace",
        "workplace statistics numerical data",
        "young adult"
    ]
}